MeVis acquires CT CAD technology from Hologic

TriMed Staff | | Health Imaging | Artificial Intelligence
 
MeVis to expand CT business with U.S. acquisition. Source: MeVisLab 
MeVis Medical Solutions has acquired all rights to CT CAD technology from R2 Technology, a subsidiary of Hologic. 

The acquisition includes the Santa Clara, Calif.-based R2’s products, technology and intellectual property for computer-aided detection (CAD), advanced visualization and multi-detector CT (MDCT) exams.

MeVis is a provider of disease-oriented software solutions for image-based medicine. The company said its addition of the R2 CT CAD products and technology provides the foundation for expanding its portfolio of workflow-optimized solutions for pulmonary imaging and oncology.

The FDA has approved ImageChecker CT, a CT lung CAD system, for the use of CAD in improving the detection of actionable lung nodules during review of MDCT chest exams.

MeVis said it will transfer R2’s CT business to its new Milwaukee-area facility and distribute the associated products under a brand name as the MeVis Visia CT lung system. 

 

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.